Management strategies for dermatomyositis during the coronavirus disease 2019 outbreak
- PMID: 33341205
- PMCID: PMC7403873
- DOI: 10.1016/j.clindermatol.2020.08.004
Management strategies for dermatomyositis during the coronavirus disease 2019 outbreak
Abstract
In late 2019, the coronavirus disease 2019 (COVID-19) broke out in Wuhan and then spread over China, which greatly affected the medical practices and health care systems. With most of the hospital's outpatient services closed, the routine clinical diagnosis and treatment for patients with dermatomyositis has been disturbed. We conducted telephone follow-up for 52 patients to know the changes in the condition and the continuation of drug therapy and to ensure the continuity, safety, and effectiveness of the treatment of patients with dermatomyositis during COVID-19.
Copyright © 2020 Elsevier Inc. All rights reserved.
Conflict of interest statement
Conflict of Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical